Incision Pain and Uterine Contraction Pain After Cesarean Section
Differences in Incision Pain and Uterine Contraction Pain After Cesarean Section Between Primary Section and Repeat Section
1 other identifier
interventional
80
0 countries
N/A
Brief Summary
This study aims to compare the pain degree between primary cesarean section and repeated cesarean section, and investigate the role of flurbiprofen axetil in postoperative analgesia, so as to provide reference for clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2015
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2015
CompletedStudy Start
First participant enrolled
November 1, 2015
CompletedFirst Posted
Study publicly available on registry
November 3, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedNovember 3, 2015
October 1, 2015
1.8 years
October 26, 2015
November 2, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The scores of incision pain and uterine contraction pain 24 h, 48 h and 72 h after operation
up to 24 months
Study Arms (4)
Group SF1
EXPERIMENTALprimary cesarean section+postoperative analgesia with sufentanil plus flurbiprofen axetil group
Group S1
EXPERIMENTALprimary cesarean section+postoperative analgesia with sufentanil group
Group SF2
EXPERIMENTALrepeated cesarean section+postoperative analgesia with sufentanil plus flurbiprofen axetil group
Group S2
EXPERIMENTALrepeated cesarean section+postoperative analgesia with sufentanil group
Interventions
primary cesarean section+postoperative analgesia with sufentanil plus flurbiprofen axetil group
sufentanil was administered for analgesia in primary cesarean section
sufentanil and flurbiprofen was administered for analgesia in repeated cesarean section
sufentanil was administered for analgesia in repeated cesarean section
Eligibility Criteria
You may qualify if:
- Eighty women undergoing elective cesarean section under general anesthesia were enrolled in this prospective observational study.
You may not qualify if:
- Diabetes controlled by insulin
- Preeclampsia
- Heart diseases
- History of taking drugs potentially affecting cardiovascular system.
- Patients fasted for at least 8 hours before surgery and no premedication was given
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fudan Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Shaoqiang Huang
Department of Anesthesiology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Obstetrics and Gynecology Hospital
Study Record Dates
First Submitted
October 26, 2015
First Posted
November 3, 2015
Study Start
November 1, 2015
Primary Completion
August 1, 2017
Study Completion
December 1, 2017
Last Updated
November 3, 2015
Record last verified: 2015-10